NCT06353828View on ClinicalTrials.gov

Phase 2a Study to Evaluate IcBD-01 Enema in Active Ulcerative Colitis Patients

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

45

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

April 1, 2024

Study Completion Date

April 1, 2025

Conditions

Ulcerative Colitis

Interventions

DRUG

CBD, synthetic form

Cannabidiol enema

DRUG

Placebo

placebo enema

Trial Locations (1)

Unknown

Meir Medical Center, Kfar Saba

Sponsors

Lead Sponsor

CannaMore Biotechs

All Listed Sponsors

lead

CannaMore Biotechs

INDUSTRY